Author: OurCrowd

[Scopio in PR Newswire] Scopio Labs launches world’s first digital application for bone marrow aspirate imaging and review 

Sep 8, 2022 | ,

TEL AVIV, Israel, Sept. 8, 2022 /PRNewswire/ — Scopio Labs, developer of Full-Field Cell Morphology™ imaging and AI-powered analysis platforms to support laboratory professionals in the detection of cancers, anemia, infections, and other blood-related diseases, announced today the launch of the Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. This platform is the first to enable a complete digital workflow for bone marrow aspirate scanning and analysis. Scopio’s high resolution Full-Field imaging and AI-driven Decision Support System brings a much-desired digital transformation to hematopathology. With embedded remote analysis capabilities over a secure hospital network, the application provides the ability to review the aspirate from any location, in the lab or from remote sites, eliminating the need for a manual microscope to perform a BMA review. Read...

Read More

[InsideTracker in PR Newswire] InsideTracker raises $15m to drive continued innovation and delivery of its leading AI platform for personalized nutrition and healthspan optimization

Sep 8, 2022 | ,

CAMBRIDGE, Mass., Sept. 8, 2022 /PRNewswire/ — InsideTracker, the leading healthspan optimization platform, announced today that it has raised $15M in Series B funding in a round led by PeakBridge with participation from Cornucopian Capital and OurCrowd, renewed participation from BASF Venture Capital GmbH, and the continued support of existing investors. Read more...

Read More